GLP-1s have taken the healthcare industry – and pop culture – by storm as an effective class of medication to help treat chronic obesity. The exploding popularity of GLP-1s for weight loss has created new challenges for employers and payers alike as they grapple with how to cover these pricey drugs. In this webinar, we’ll discuss the history of GLP-1s in the midst of the rise of obesity and type-2 diabetes in the U.S., why a clinically-rigorous approach to diabetes prevention and care is so important, and the big picture of what GLP-1s mean for the business of treating diabetes and obesity.
Our 60 minute webinar on June 28th, 2023 explored the following:
- Balancing GLP-1s as an effective medication with strategies to deliver savings
- Improving outcomes by pairing GLP-1s with evidence-based behavior change
- Evaluating benefit philosophy regarding coverage of weight loss medications
Presenters:
Sean Duffy, Co-founder and CEO, Omada Health
Prachi Nagda, MD, MPA, Clinical Services Physician, Mercer
